Ambetter's claims system flags this
When Wegovy triggers an allergic reaction, mast cells in the skin release histamine and other inflammatory mediators
Since food intake doesn't alter semaglutide's effectiveness, choose the timing that matches your lifestyle and makes adherence easiest
Gastrointestinal issues such as nausea, vomiting, constipation and diarrhoea are common, with more serious complications including gallbladder inflammation and pancreatitis reported in a minority of patients
Common gastrointestinal effects reported with GLP-1 therapy include: Nausea (commonly reported, especially during dose escalation) Constipation or diarrhoea Abdominal discomfort or bloating Reduced appetite and early satiety Regarding bowel movement colour specifically, changes in stool colour are not listed as adverse effects in UK SmPCs for GLP-1 receptor agonists
Factors That Influence Results Results reflect more than the name on the label